Augmont Enterprises IPO
₹750 – ₹750 · Issue Size ₹825 CrIPO Overview
Business Model
- Deep domain knowledge of the gold and silver industry with an integrated model and a well-established brand
- We have accumulated deep domain knowledge of the gold and silver industry through several years of our
- Our ‘Augmont SPOT’ platform, which is a fully electronic, over-the-counter delivery-based bullion platform
IPO Timeline
Listing Performance
Risk Factors
Private Limited (Formerly Link Intime India Private Limited)
Strengths & Weaknesses
Strengths
- Deep domain knowledge of the gold and silver industry with an integrated model and a well-established brand
- We have accumulated deep domain knowledge of the gold and silver industry through several years of our
- Our ‘Augmont SPOT’ platform, which is a fully electronic, over-the-counter delivery-based bullion platform
Management & Promoters
Peer Comparison
| Company | P/E | EPS |
|---|---|---|
| Augmont Enterprises IPO | — | — |
| (Please read Section of the Companies Act ) | 32.0x | — |
Pre-IPO Financials
| Period | Revenue (Cr) | PAT (Cr) | Net Worth (Cr) | Total Assets (Cr) |
|---|---|---|---|---|
| March 2025 | ₹66,230.78 Cr | ₹-0.2 Cr | ₹4.5 Cr | — |
| March 2024 | ₹34,921.49 Cr | — | ₹4.5 Cr | — |
| March 2023 | ₹31,289.31 Cr | — | ₹4.5 Cr | — |
About
Q-Line Biotech Ltd. (QBL) is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributor/s majorly to diagnostic service providers, hospitals and medica
Key Regulations and Policies", "Statement of Special Tax Benefits", "Financial Statements", "Basis for Offer Price", "History and Certain Corporate Matters", "Financial Indebtedness", "Other Regulatory and Statutory Disclosures", "Management’s Discussion and Analysis of Financial Condition and Results of Operations", "Outstanding Litigation and Material Developments" and
| Exchange | NSE |
| Issue Type | mainboard |
| Face Value | ₹5 per share |
Documents
rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.